NCT00047229 Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) Status COMPLETED Phase PHASE2
NCT00041275 Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE3
NCT00040898 Sho-Saiko-To Following Removal of Liver Cancer By Embolization in Treating Patients With Liver Cancer That Cannot Be Surgically Removed Status COMPLETED Phase PHASE2
NCT00039078 Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery Status WITHDRAWN Phase PHASE2
NCT00036959 ABT-751 in Treating Young Patients With Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00030511 Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer Status TERMINATED Phase PHASE2
NCT00030108 Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy Status COMPLETED Phase PHASE1
NCT00030082 Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer Status COMPLETED Phase PHASE1
NCT00027768 Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer Status UNKNOWN Phase PHASE3
NCT00027534 Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1
NCT00024258 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors Status COMPLETED Phase PHASE2
NCT00022334 Vaccine Therapy in Treating Patients With Liver Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00021047 Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor Status COMPLETED Phase PHASE1/PHASE2
NCT00020774 SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer Status WITHDRAWN Phase PHASE2
NCT00020150 Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors Status COMPLETED Phase PHASE1
NCT00019786 Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases Status COMPLETED Phase PHASE2
NCT00019604 Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver Cancer Status TERMINATED Phase PHASE2
NCT00019513 Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas Status COMPLETED Phase PHASE1
NCT00019474 Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer Status COMPLETED Phase PHASE2